Featured Research

from universities, journals, and other organizations

Mucus: Fighting the war against pollutants

Date:
May 23, 2011
Source:
American Friends of Tel Aviv University
Summary:
Researchers have found that mucus, which was thought to protect our bodies against harmful pollutants, in fact may leave our bodies more vulnerable to them. But the discovery may prove useful in enabling some drugs to enter cells and treat diseases like cancer.

Are our bodies vulnerable to some pollutants whose lack of solubility in water, or "hydrophobicity," has always been thought to protect us from them? New Tel Aviv University research has discovered that this is indeed the case.

Studies by Dr. Michael Gozin of Tel Aviv University's School of Chemistry at the Raymond and Beverly Sackler Faculty of Exact Sciences and Dr. Dan Peer of TAU's Laboratory of Nanomedicine in the Department of Cell Research and Immunology have revealed that mucus -- the thick substance lining those internal bodily organs that come into contact with the outer environment, such as the respiratory system, the digestive system, and the female reproductive system -- may instead play an active role in the penetration of hydrophobic substances, including toxins and carcinogens, into our cells.

But encouragingly, the researchers believe that their discovery will one day prove useful in enabling non-water-soluble drugs to enter cells and treat diseases such as cancer. Their most recent study was published in the American Chemical Society's Chemical Research in Toxicology journal.

When mucus fails

Some of these dangerous substances, such as polycyclic aromatic hydrocarbons, are present in petroleum products and also formed through the partial combustion of fossil fuels that are used to operate power stations, planes, cars, space heaters, and stoves. In the new publication, Drs. Gozin and Peer describe their success in getting certain substances, some of them toxic, to penetrate digestive-system cell cultures and bacterial cells bathed in a mucus solution.

"Until now, mucus has been regarded as a mechanical and chemical protective membrane. We did not expect to find it actually absorbing these toxic hydrocarbons and facilitating their transport into bodily systems," explains Dr. Gozin.

Dr. Gozin, Dr. Peer and their research teams show that petroleum-based toxins can dissolve in water with the aid of mucins, the proteins that constitute the main component of mucus.

A new drug delivery system?

In their laboratory, Drs. Gozin and Peer bathed single-celled organisms in a solution of the hydrocarbon-mucin complex, and observed that the hydrocarbons penetrated the cells much more rapidly than when no mucins were present. "We do not know what mechanism enables these substances to penetrate the cell membranes. Clearly it is not a simple infiltration. Our assumption is that an endocytosis-like process is at work -- substances are being absorbed into the cell through entrapment, with the cell membrane folding in on itself and creating a bubble," Dr. Gozin explains.

In an earlier study, published in 2010 in the nanotechnology journal Small, Dr. Gozin's team demonstrated that nanometer-scale substances such as carbon-based and inorganic fullerenes (ball-shaped nanoparticles) as well as carbon nanotubes can also be dispersed in physiological solutions with the aid of mucins.

"It will be possible to employ the mechanism we have discovered to facilitate the penetration of hydrophobic drugs into the body, whether via the respiratory tract -- with drugs entering the body through the lungs -- or by swallowing a delayed-release drug formulation to be absorbed by the digestive system beyond the stomach," Dr. Gozin notes. The next stage of the research will focus on developing systems for the transport of hydrophobic drugs.


Story Source:

The above story is based on materials provided by American Friends of Tel Aviv University. Note: Materials may be edited for content and length.


Journal References:

  1. Eyal Drug, Dalit Landesman-Milo, Bogdan Belgorodsky, Natalia Ermakov, Moran Frenkel-Pinter, Ludmila Fadeev, Dan Peer, Michael Gozin. Enhanced Bioavailability of Polyaromatic Hydrocarbons in the Form of Mucin Complexes. Chemical Research in Toxicology, 2011; 24 (3): 314 DOI: 10.1021/tx100426s
  2. Bogdan Belgorodsky, Eyal Drug, Ludmila Fadeev, Netta Hendler, Elad Mentovich, Michael Gozin. Mucin Complexes of Nanomaterials: First Biochemical Encounter. Small, 2010; 6 (2): 262 DOI: 10.1002/smll.200900637

Cite This Page:

American Friends of Tel Aviv University. "Mucus: Fighting the war against pollutants." ScienceDaily. ScienceDaily, 23 May 2011. <www.sciencedaily.com/releases/2011/03/110330094018.htm>.
American Friends of Tel Aviv University. (2011, May 23). Mucus: Fighting the war against pollutants. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2011/03/110330094018.htm
American Friends of Tel Aviv University. "Mucus: Fighting the war against pollutants." ScienceDaily. www.sciencedaily.com/releases/2011/03/110330094018.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins